Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Multicenter Phase II Study of Bevacizumab for the Treatment of Angiosarcoma

NCT00288015 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT00288015
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00288015 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Multicenter Phase II Study of Bevacizumab for the Treatment of Angiosarcoma
Lead sponsor
Northwestern University
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2005
Completion date
November 10, 2016
Enrollment
32 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoma